Extended treatment with fingolimod for relapsing multiple sclerosis: the 14-year LONGTERMS study results
Background: Multiple sclerosis (MS) is a chronic disease that may require decades of ongoing treatment. Therefore, the long-term safety and efficacy of disease-modifying therapies is an important consideration. Methods: The LONGTERMS study evaluated the safety and efficacy of fingolimod in patients...
Guardat en:
| Autors principals: | , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
SAGE Publishing
2019-09-01
|
| Col·lecció: | Therapeutic Advances in Neurological Disorders |
| Accés en línia: | https://doi.org/10.1177/1756286419878324 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|